Editas Medicine to Present at the 35th Annual J.P. Morgan Healthcare Conference
January 04 2017 - 8:01AM
Editas Medicine, Inc. (NASDAQ:EDIT), a leading genome editing
company, today announced that it will present a company overview
followed by a question and answer session at the 35th Annual J.P.
Morgan Healthcare Conference on Wednesday, January 11, 2017, at
11:30 a.m. PT in San Francisco, CA.
A live webcast of the presentation and question
and answer session will be available on the Investors & Media
section of the Editas website at www.editasmedicine.com. An
archived replay will be available for approximately 30 days
following the presentation.
About Editas MedicineEditas
Medicine is a leading genome editing company dedicated to treating
patients with genetically-defined diseases by correcting their
disease-causing genes. The company was founded by world
leaders in genome editing, and its mission is to translate the
promise of genome editing science into a broad class of
transformative genomic medicines to benefit the greatest number of
patients.
Media Contact
Dan Budwick
Pure Communications, Inc.
(973) 271-6085
dan@purecommunicationsinc.com
Investor Contact
Mark Mullikin
Editas Medicine, Inc.
(617) 401-9083
mark.mullikin@editasmed.com
Editas Medicine (NASDAQ:EDIT)
Historical Stock Chart
From Aug 2024 to Sep 2024
Editas Medicine (NASDAQ:EDIT)
Historical Stock Chart
From Sep 2023 to Sep 2024